<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2018-01-31" version="221">
<accession>P31749</accession>
<accession>B2RAM5</accession>
<accession>B7Z5R1</accession>
<accession>Q9BWB6</accession>
<name>AKT1_HUMAN</name>
<protein>
<recommendedName>
<fullName>RAC-alpha serine/threonine-protein kinase</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Protein kinase B</fullName>
<shortName>PKB</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein kinase B alpha</fullName>
<shortName>PKB alpha</shortName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Akt</fullName>
</alternativeName>
<alternativeName>
<fullName>RAC-PK-alpha</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AKT1</name>
<name type="synonym">PKB</name>
<name type="synonym">RAC</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="4171" last="4175">
<title>Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily.</title>
<authorList>
<person name="Jones P.F."/>
<person name="Jakubowicz T."/>
<person name="Pitossi F.J."/>
<person name="Maurer F."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="1851997"/>
<dbReference type="DOI" id="10.1073/pnas.88.10.4171"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="Diabetologia" volume="44" first="910" last="913">
<title>Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphisms (SNPs), and their lack of association with Type II diabetes.</title>
<authorList>
<person name="Matsubara A."/>
<person name="Wasson J.C."/>
<person name="Donelan S.S."/>
<person name="Welling C.M."/>
<person name="Glaser B."/>
<person name="Permutt M.A."/>
</authorList>
<dbReference type="PubMed" id="11508278"/>
<dbReference type="DOI" id="10.1007/s001250100577"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Adrenal gland</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="421" first="601" last="607">
<title>The DNA sequence and analysis of human chromosome 14.</title>
<authorList>
<person name="Heilig R."/>
<person name="Eckenberg R."/>
<person name="Petit J.-L."/>
<person name="Fonknechten N."/>
<person name="Da Silva C."/>
<person name="Cattolico L."/>
<person name="Levy M."/>
<person name="Barbe V."/>
<person name="De Berardinis V."/>
<person name="Ureta-Vidal A."/>
<person name="Pelletier E."/>
<person name="Vico V."/>
<person name="Anthouard V."/>
<person name="Rowen L."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Sun H."/>
<person name="Du H."/>
<person name="Pepin K."/>
<person name="Artiguenave F."/>
<person name="Robert C."/>
<person name="Cruaud C."/>
<person name="Bruels T."/>
<person name="Jaillon O."/>
<person name="Friedlander L."/>
<person name="Samson G."/>
<person name="Brottier P."/>
<person name="Cure S."/>
<person name="Segurens B."/>
<person name="Aniere F."/>
<person name="Samain S."/>
<person name="Crespeau H."/>
<person name="Abbasi N."/>
<person name="Aiach N."/>
<person name="Boscus D."/>
<person name="Dickhoff R."/>
<person name="Dors M."/>
<person name="Dubois I."/>
<person name="Friedman C."/>
<person name="Gouyvenoux M."/>
<person name="James R."/>
<person name="Madan A."/>
<person name="Mairey-Estrada B."/>
<person name="Mangenot S."/>
<person name="Martins N."/>
<person name="Menard M."/>
<person name="Oztas S."/>
<person name="Ratcliffe A."/>
<person name="Shaffer T."/>
<person name="Trask B."/>
<person name="Vacherie B."/>
<person name="Bellemere C."/>
<person name="Belser C."/>
<person name="Besnard-Gonnet M."/>
<person name="Bartol-Mavel D."/>
<person name="Boutard M."/>
<person name="Briez-Silla S."/>
<person name="Combette S."/>
<person name="Dufosse-Laurent V."/>
<person name="Ferron C."/>
<person name="Lechaplais C."/>
<person name="Louesse C."/>
<person name="Muselet D."/>
<person name="Magdelenat G."/>
<person name="Pateau E."/>
<person name="Petit E."/>
<person name="Sirvain-Trukniewicz P."/>
<person name="Trybou A."/>
<person name="Vega-Czarny N."/>
<person name="Bataille E."/>
<person name="Bluet E."/>
<person name="Bordelais I."/>
<person name="Dubois M."/>
<person name="Dumont C."/>
<person name="Guerin T."/>
<person name="Haffray S."/>
<person name="Hammadi R."/>
<person name="Muanga J."/>
<person name="Pellouin V."/>
<person name="Robert D."/>
<person name="Wunderle E."/>
<person name="Gauguet G."/>
<person name="Roy A."/>
<person name="Sainte-Marthe L."/>
<person name="Verdier J."/>
<person name="Verdier-Discala C."/>
<person name="Hillier L.W."/>
<person name="Fulton L."/>
<person name="McPherson J."/>
<person name="Matsuda F."/>
<person name="Wilson R."/>
<person name="Scarpelli C."/>
<person name="Gyapay G."/>
<person name="Wincker P."/>
<person name="Saurin W."/>
<person name="Quetier F."/>
<person name="Waterston R."/>
<person name="Hood L."/>
<person name="Weissenbach J."/>
</authorList>
<dbReference type="PubMed" id="12508121"/>
<dbReference type="DOI" id="10.1038/nature01348"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Muscle</tissue>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Eur. J. Biochem." volume="201" first="475" last="481">
<title>Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families.</title>
<authorList>
<person name="Coffer P.J."/>
<person name="Woodgett J.R."/>
</authorList>
<dbReference type="PubMed" id="1718748"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1991.tb16305.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 63-480 (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Foreskin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="Eur. J. Biochem." volume="205" first="1217" last="1218">
<authorList>
<person name="Coffer P.J."/>
<person name="Woodgett J.R."/>
</authorList>
<dbReference type="PubMed" id="1533586"/>
</citation>
<scope>ERRATUM</scope>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="32377" last="32379">
<title>CREB is a regulatory target for the protein kinase Akt/PKB.</title>
<authorList>
<person name="Du K."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="9829964"/>
<dbReference type="DOI" id="10.1074/jbc.273.49.32377"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CREB1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="11211" last="11216">
<title>Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.</title>
<authorList>
<person name="Delcommenne M."/>
<person name="Tan C."/>
<person name="Gray V."/>
<person name="Rue L."/>
<person name="Woodgett J.R."/>
<person name="Dedhar S."/>
</authorList>
<dbReference type="PubMed" id="9736715"/>
<dbReference type="DOI" id="10.1073/pnas.95.19.11211"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT SER-473</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="EMBO J." volume="15" first="6541" last="6551">
<title>Mechanism of activation of protein kinase B by insulin and IGF-1.</title>
<authorList>
<person name="Alessi D.R."/>
<person name="Andjelkovic M."/>
<person name="Caudwell F.B."/>
<person name="Cron P."/>
<person name="Morrice N."/>
<person name="Cohen P."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="8978681"/>
</citation>
<scope>MUTAGENESIS OF THR-308 AND SER-473</scope>
<scope>PHOSPHORYLATION AT THR-308 AND SER-473</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Biochem. J." volume="331" first="299" last="308">
<title>Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha.</title>
<authorList>
<person name="Walker K.S."/>
<person name="Deak M."/>
<person name="Paterson A."/>
<person name="Hudson K."/>
<person name="Cohen P."/>
<person name="Alessi D.R."/>
</authorList>
<dbReference type="PubMed" id="9512493"/>
<dbReference type="DOI" id="10.1042/bj3310299"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT THR-308 BY PDPK1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17179" last="17183">
<title>Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.</title>
<authorList>
<person name="Rena G."/>
<person name="Guo S."/>
<person name="Cichy S.C."/>
<person name="Unterman T.G."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="10358075"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.17179"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF FOXO1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Science" volume="286" first="1741" last="1744">
<title>Phosphorylation and regulation of Raf by Akt (protein kinase B).</title>
<authorList>
<person name="Zimmermann S."/>
<person name="Moelling K."/>
</authorList>
<dbReference type="PubMed" id="10576742"/>
<dbReference type="DOI" id="10.1126/science.286.5445.1741"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RAF1</scope>
<scope>INTERACTION WITH RAF1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="34451" last="34458">
<title>Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage.</title>
<authorList>
<person name="Koh H."/>
<person name="Lee K.H."/>
<person name="Kim D."/>
<person name="Kim S."/>
<person name="Kim J.W."/>
<person name="Chung J."/>
</authorList>
<dbReference type="PubMed" id="10926925"/>
<dbReference type="DOI" id="10.1074/jbc.M001753200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BAD</scope>
<scope>INTERACTION WITH BAD AND PKN2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Mol. Cell" volume="6" first="395" last="407">
<title>The protooncogene TCL1 is an Akt kinase coactivator.</title>
<authorList>
<person name="Laine J."/>
<person name="Kuenstle G."/>
<person name="Obata T."/>
<person name="Sha M."/>
<person name="Noguchi M."/>
</authorList>
<dbReference type="PubMed" id="10983986"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)00039-3"/>
</citation>
<scope>INTERACTION WITH MTCP1; TCL1A AND TCL1B</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="3028" last="3033">
<title>Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.</title>
<authorList>
<person name="Pekarsky Y."/>
<person name="Koval A."/>
<person name="Hallas C."/>
<person name="Bichi R."/>
<person name="Tresini M."/>
<person name="Malstrom S."/>
<person name="Russo G."/>
<person name="Tsichlis P."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="10716693"/>
<dbReference type="DOI" id="10.1073/pnas.97.7.3028"/>
</citation>
<scope>INTERACTION WITH TCL1A</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="893" last="901">
<title>Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1.</title>
<authorList>
<person name="Kim A.H."/>
<person name="Khursigara G."/>
<person name="Sun X."/>
<person name="Franke T.F."/>
<person name="Chao M.V."/>
</authorList>
<dbReference type="PubMed" id="11154276"/>
<dbReference type="DOI" id="10.1128/MCB.21.3.893-901.2001"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MAP3K5</scope>
<scope>INTERACTION WITH MAP3K5</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Science" volume="294" first="374" last="380">
<title>Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane.</title>
<authorList>
<person name="Maira S.-M."/>
<person name="Galetic I."/>
<person name="Brazil D.P."/>
<person name="Kaech S."/>
<person name="Ingley E."/>
<person name="Thelen M."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="11598301"/>
<dbReference type="DOI" id="10.1126/science.1062030"/>
</citation>
<scope>INTERACTION WITH THEM4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="22115" last="22118">
<title>A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain.</title>
<authorList>
<person name="Kane S."/>
<person name="Sano H."/>
<person name="Liu S.C.H."/>
<person name="Asara J.M."/>
<person name="Lane W.S."/>
<person name="Garner C.C."/>
<person name="Lienhard G.E."/>
</authorList>
<dbReference type="PubMed" id="11994271"/>
<dbReference type="DOI" id="10.1074/jbc.C200198200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TBC1D4</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="28706" last="28713">
<title>Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.</title>
<authorList>
<person name="Fujita N."/>
<person name="Sato S."/>
<person name="Katayama K."/>
<person name="Tsuruo T."/>
</authorList>
<dbReference type="PubMed" id="12042314"/>
<dbReference type="DOI" id="10.1074/jbc.M203668200"/>
</citation>
<scope>INTERACTION WITH CDKN1B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="38021" last="38028">
<title>Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase.</title>
<authorList>
<person name="Conus N.M."/>
<person name="Hannan K.M."/>
<person name="Cristiano B.E."/>
<person name="Hemmings B.A."/>
<person name="Pearson R.B."/>
</authorList>
<dbReference type="PubMed" id="12149249"/>
<dbReference type="DOI" id="10.1074/jbc.M203387200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-474</scope>
<scope>MUTAGENESIS OF TYR-474</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Mol. Cell" volume="10" first="151" last="162">
<title>Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.</title>
<authorList>
<person name="Manning B.D."/>
<person name="Tee A.R."/>
<person name="Logsdon M.N."/>
<person name="Blenis J."/>
<person name="Cantley L.C."/>
</authorList>
<dbReference type="PubMed" id="12150915"/>
<dbReference type="DOI" id="10.1016/S1097-2765(02)00568-3"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TSC2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="1513" last="1525">
<title>Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.</title>
<authorList>
<person name="Kuenstle G."/>
<person name="Laine J."/>
<person name="Pierron G."/>
<person name="Kagami S."/>
<person name="Nakajima H."/>
<person name="Hoh F."/>
<person name="Roumestand C."/>
<person name="Stern M.H."/>
<person name="Noguchi M."/>
</authorList>
<dbReference type="PubMed" id="11839817"/>
<dbReference type="DOI" id="10.1128/MCB.22.5.1513-1525.2002"/>
</citation>
<scope>INTERACTION WITH TCL1A</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Nat. Med." volume="8" first="1145" last="1152">
<title>PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.</title>
<authorList>
<person name="Shin I."/>
<person name="Yakes F.M."/>
<person name="Rojo F."/>
<person name="Shin N.-Y."/>
<person name="Bakin A.V."/>
<person name="Baselga J."/>
<person name="Arteaga C.L."/>
</authorList>
<dbReference type="PubMed" id="12244301"/>
<dbReference type="DOI" id="10.1038/nm759"/>
</citation>
<scope>INTERACTION WITH CDKN1B</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF THR-308 AND SER-473</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="Exp. Cell Res." volume="288" first="110" last="118">
<title>Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk.</title>
<authorList>
<person name="Lennartsson J."/>
<person name="Wernstedt C."/>
<person name="Engstrom U."/>
<person name="Hellman U."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="12878163"/>
<dbReference type="DOI" id="10.1016/S0014-4827(03)00206-4"/>
</citation>
<scope>FUNCTION IN PARTICIPATION IN KIT SIGNALING</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="16441" last="16451">
<title>PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion.</title>
<authorList>
<person name="Ahn J.-Y."/>
<person name="Rong R."/>
<person name="Kroll T.G."/>
<person name="Van Meir E.G."/>
<person name="Snyder S.H."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="14761976"/>
<dbReference type="DOI" id="10.1074/jbc.M312175200"/>
</citation>
<scope>INTERACTION WITH AGAP2</scope>
<scope>PHOSPHORYLATION AT SER-473</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="23151" last="23157">
<title>LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway.</title>
<authorList>
<person name="Kunapuli P."/>
<person name="Kasyapa C.S."/>
<person name="Hawthorn L."/>
<person name="Cowell J.K."/>
</authorList>
<dbReference type="PubMed" id="15047712"/>
<dbReference type="DOI" id="10.1074/jbc.M314192200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-473</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="2752" last="2752">
<authorList>
<person name="Kunapuli P."/>
<person name="Kasyapa C.S."/>
<person name="Hawthorn L."/>
<person name="Cowell J.K."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="1493" last="1504">
<title>Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt.</title>
<authorList>
<person name="Remy I."/>
<person name="Michnick S.W."/>
</authorList>
<dbReference type="PubMed" id="14749367"/>
<dbReference type="DOI" id="10.1128/MCB.24.4.1493-1504.2004"/>
</citation>
<scope>INTERACTION WITH AKTIP</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="6993" last="6998">
<title>PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.</title>
<authorList>
<person name="Ahn J.-Y."/>
<person name="Hu Y."/>
<person name="Kroll T.G."/>
<person name="Allard P."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="15118108"/>
<dbReference type="DOI" id="10.1073/pnas.0400921101"/>
</citation>
<scope>INTERACTION WITH AGAP2</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="9643" last="9650">
<title>Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation.</title>
<authorList>
<person name="Brandts C.H."/>
<person name="Sargin B."/>
<person name="Rode M."/>
<person name="Biermann C."/>
<person name="Lindtner B."/>
<person name="Schwable J."/>
<person name="Buerger H."/>
<person name="Muller-Tidow C."/>
<person name="Choudhary C."/>
<person name="McMahon M."/>
<person name="Berdel W.E."/>
<person name="Serve H."/>
</authorList>
<dbReference type="PubMed" id="16266983"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-0422"/>
</citation>
<scope>PHOSPHORYLATION AT SER-473 IN RESPONSE TO FLT3 SIGNALING</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Dev. Cell" volume="9" first="389" last="402">
<title>Akt/PKB regulates actin organization and cell motility via Girdin/APE.</title>
<authorList>
<person name="Enomoto A."/>
<person name="Murakami H."/>
<person name="Asai N."/>
<person name="Morone N."/>
<person name="Watanabe T."/>
<person name="Kawai K."/>
<person name="Murakumo Y."/>
<person name="Usukura J."/>
<person name="Kaibuchi K."/>
<person name="Takahashi M."/>
</authorList>
<dbReference type="PubMed" id="16139227"/>
<dbReference type="DOI" id="10.1016/j.devcel.2005.08.001"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH CCDC88A</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Science" volume="307" first="1098" last="1101">
<title>Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.</title>
<authorList>
<person name="Sarbassov D.D."/>
<person name="Guertin D.A."/>
<person name="Ali S.M."/>
<person name="Sabatini D.M."/>
</authorList>
<dbReference type="PubMed" id="15718470"/>
<dbReference type="DOI" id="10.1126/science.1106148"/>
</citation>
<scope>PHOSPHORYLATION AT THR-308</scope>
<scope>PHOSPHORYLATION AT SER-473 BY MTOR</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Acta Neuropathol." volume="112" first="715" last="725">
<title>Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.</title>
<authorList>
<person name="Schick V."/>
<person name="Majores M."/>
<person name="Engels G."/>
<person name="Spitoni S."/>
<person name="Koch A."/>
<person name="Elger C.E."/>
<person name="Simon M."/>
<person name="Knobbe C."/>
<person name="Bluemcke I."/>
<person name="Becker A.J."/>
</authorList>
<dbReference type="PubMed" id="17013611"/>
<dbReference type="DOI" id="10.1007/s00401-006-0128-y"/>
</citation>
<scope>PHOSPHORYLATION AT SER-473</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Biochem. J." volume="399" first="9" last="20">
<title>A WD-FYVE protein binds to the kinases Akt and PKCzeta/lambda.</title>
<authorList>
<person name="Fritzius T."/>
<person name="Burkard G."/>
<person name="Haas E."/>
<person name="Heinrich J."/>
<person name="Schweneker M."/>
<person name="Bosse M."/>
<person name="Zimmermann S."/>
<person name="Frey A.D."/>
<person name="Caelers A."/>
<person name="Bachmann A.S."/>
<person name="Moelling K."/>
</authorList>
<dbReference type="PubMed" id="16792529"/>
<dbReference type="DOI" id="10.1042/BJ20060511"/>
</citation>
<scope>INTERACTION WITH WDFY2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="Biochem. J." volume="395" first="653" last="662">
<title>Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.</title>
<authorList>
<person name="Srinivas H."/>
<person name="Xia D."/>
<person name="Moore N.L."/>
<person name="Uray I.P."/>
<person name="Kim H."/>
<person name="Ma L."/>
<person name="Weigel N.L."/>
<person name="Brown P.H."/>
<person name="Kurie J.M."/>
</authorList>
<dbReference type="PubMed" id="16417524"/>
<dbReference type="DOI" id="10.1042/BJ20051794"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RARA</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="13949" last="13956">
<title>Kinetic mechanism of AKT/PKB enzyme family.</title>
<authorList>
<person name="Zhang X."/>
<person name="Zhang S."/>
<person name="Yamane H."/>
<person name="Wahl R."/>
<person name="Ali A."/>
<person name="Lofgren J.A."/>
<person name="Kendall R.L."/>
</authorList>
<dbReference type="PubMed" id="16540465"/>
<dbReference type="DOI" id="10.1074/jbc.M601384200"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="8267" last="8280">
<title>Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.</title>
<authorList>
<person name="Heron-Milhavet L."/>
<person name="Franckhauser C."/>
<person name="Rana V."/>
<person name="Berthenet C."/>
<person name="Fisher D."/>
<person name="Hemmings B.A."/>
<person name="Fernandez A."/>
<person name="Lamb N.J."/>
</authorList>
<dbReference type="PubMed" id="16982699"/>
<dbReference type="DOI" id="10.1128/MCB.00201-06"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CDKN1A</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="4523" last="4534">
<title>The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1.</title>
<authorList>
<person name="Cinar B."/>
<person name="Fang P.K."/>
<person name="Lutchman M."/>
<person name="Di Vizio D."/>
<person name="Adam R.M."/>
<person name="Pavlova N."/>
<person name="Rubin M.A."/>
<person name="Yelick P.C."/>
<person name="Freeman M.R."/>
</authorList>
<dbReference type="PubMed" id="17932490"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601872"/>
</citation>
<scope>INTERACTION WITH STK4/MST1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="30836" last="30844">
<title>Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation.</title>
<authorList>
<person name="Jang S.W."/>
<person name="Yang S.J."/>
<person name="Srinivasan S."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="17726016"/>
<dbReference type="DOI" id="10.1074/jbc.M704542200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STK4/MST1</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Anticancer Res." volume="28" first="957" last="963">
<title>Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells.</title>
<authorList>
<person name="Han E.K."/>
<person name="Mcgonigal T."/>
<person name="Butler C."/>
<person name="Giranda V.L."/>
<person name="Luo Y."/>
</authorList>
<dbReference type="PubMed" id="18507042"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PROHIBITIN</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; SER-126 AND SER-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2009" name="Dev. Cell" volume="17" first="800" last="810">
<title>The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt.</title>
<authorList>
<person name="Suizu F."/>
<person name="Hiramuki Y."/>
<person name="Okumura F."/>
<person name="Matsuda M."/>
<person name="Okumura A.J."/>
<person name="Hirata N."/>
<person name="Narita M."/>
<person name="Kohno T."/>
<person name="Yokota J."/>
<person name="Bohgaki M."/>
<person name="Obuse C."/>
<person name="Hatakeyama S."/>
<person name="Obata T."/>
<person name="Noguchi M."/>
</authorList>
<dbReference type="PubMed" id="20059950"/>
<dbReference type="DOI" id="10.1016/j.devcel.2009.09.007"/>
</citation>
<scope>UBIQUITINATION BY TTC3</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="24512" last="24525">
<title>Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons.</title>
<authorList>
<person name="Jang S.W."/>
<person name="Liu X."/>
<person name="Fu H."/>
<person name="Rees H."/>
<person name="Yepes M."/>
<person name="Levey A."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="19592491"/>
<dbReference type="DOI" id="10.1074/jbc.M109.026237"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF SRPK2</scope>
<scope>INTERACTION WITH SRPK2</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="4535" last="4546">
<title>The Rho-family GEF Asef2 activates Rac to modulate adhesion and actin dynamics and thereby regulate cell migration.</title>
<authorList>
<person name="Bristow J.M."/>
<person name="Sellers M.H."/>
<person name="Majumdar D."/>
<person name="Anderson B."/>
<person name="Hu L."/>
<person name="Webb D.J."/>
</authorList>
<dbReference type="PubMed" id="19934221"/>
<dbReference type="DOI" id="10.1242/jcs.053728"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Science" volume="325" first="1134" last="1138">
<title>The E3 ligase TRAF6 regulates Akt ubiquitination and activation.</title>
<authorList>
<person name="Yang W.-L."/>
<person name="Wang J."/>
<person name="Chan C.-H."/>
<person name="Lee S.-W."/>
<person name="Campos A.D."/>
<person name="Lamothe B."/>
<person name="Hur L."/>
<person name="Grabiner B.C."/>
<person name="Lin X."/>
<person name="Darnay B.G."/>
<person name="Lin H.-K."/>
</authorList>
<dbReference type="PubMed" id="19713527"/>
<dbReference type="DOI" id="10.1126/science.1175065"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH TRAF6</scope>
<scope>MUTAGENESIS OF LYS-8 AND LYS-14</scope>
<scope>CHARACTERIZATION OF VARIANT BREAST CANCER LYS-17</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="1195" last="1203">
<title>Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.</title>
<authorList>
<person name="Romano D."/>
<person name="Matallanas D."/>
<person name="Weitsman G."/>
<person name="Preisinger C."/>
<person name="Ng T."/>
<person name="Kolch W."/>
</authorList>
<dbReference type="PubMed" id="20086174"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-09-3147"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STK3/MST2</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3815" last="3824">
<title>Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.</title>
<authorList>
<person name="Yuan Z."/>
<person name="Kim D."/>
<person name="Shu S."/>
<person name="Wu J."/>
<person name="Guo J."/>
<person name="Xiao L."/>
<person name="Kaneko S."/>
<person name="Coppola D."/>
<person name="Cheng J.Q."/>
</authorList>
<dbReference type="PubMed" id="19940129"/>
<dbReference type="DOI" id="10.1074/jbc.M109.059675"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="31157" last="31163">
<title>Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT controls cell survival after ionizing radiation.</title>
<authorList>
<person name="Nam S.Y."/>
<person name="Seo H.H."/>
<person name="Park H.S."/>
<person name="An S."/>
<person name="Kim J.Y."/>
<person name="Yang K.H."/>
<person name="Kim C.S."/>
<person name="Jeong M."/>
<person name="Jin Y.W."/>
</authorList>
<dbReference type="PubMed" id="20682768"/>
<dbReference type="DOI" id="10.1074/jbc.M110.122044"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CLK2</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Mol. Cell" volume="38" first="333" last="344">
<title>The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration.</title>
<authorList>
<person name="Chin Y.R."/>
<person name="Toker A."/>
</authorList>
<dbReference type="PubMed" id="20471940"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.02.031"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PALLD</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9616" last="E9616">
<title>Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway.</title>
<authorList>
<person name="Kim D."/>
<person name="Shu S."/>
<person name="Coppola M.D."/>
<person name="Kaneko S."/>
<person name="Yuan Z.Q."/>
<person name="Cheng J.Q."/>
</authorList>
<dbReference type="PubMed" id="20231902"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009616"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STK3/MST2</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9646" last="E9646">
<title>Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.</title>
<authorList>
<person name="Mahajan K."/>
<person name="Coppola D."/>
<person name="Challa S."/>
<person name="Fang B."/>
<person name="Chen Y.A."/>
<person name="Zhu W."/>
<person name="Lopez A.S."/>
<person name="Koomen J."/>
<person name="Engelman R.W."/>
<person name="Rivera C."/>
<person name="Muraoka-Cook R.S."/>
<person name="Cheng J.Q."/>
<person name="Schoenbrunn E."/>
<person name="Sebti S.M."/>
<person name="Earp H.S."/>
<person name="Mahajan N.P."/>
</authorList>
<dbReference type="PubMed" id="20333297"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009646"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-176; THR-308 AND SER-473</scope>
<scope>MUTAGENESIS OF TYR-176</scope>
<scope>INTERACTION WITH TNK2</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Eur. J. Cell Biol." volume="90" first="420" last="431">
<title>Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.</title>
<authorList>
<person name="Joo H.M."/>
<person name="Kim J.Y."/>
<person name="Jeong J.B."/>
<person name="Seong K.M."/>
<person name="Nam S.Y."/>
<person name="Yang K.H."/>
<person name="Kim C.S."/>
<person name="Kim H.S."/>
<person name="Jeong M."/>
<person name="An S."/>
<person name="Jin Y.W."/>
</authorList>
<dbReference type="PubMed" id="21333377"/>
<dbReference type="DOI" id="10.1016/j.ejcb.2010.12.001"/>
</citation>
<scope>INTERACTION WITH TRIM13</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2011" name="Mol. Cell" volume="41" first="471" last="479">
<title>Clk2 and B56-beta mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt.</title>
<authorList>
<person name="Rodgers J.T."/>
<person name="Vogel R.O."/>
<person name="Puigserver P."/>
</authorList>
<dbReference type="PubMed" id="21329884"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.02.007"/>
</citation>
<scope>INTERACTION WITH PPP2R5B</scope>
<scope>DEPHOSPHORYLATION</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E51413" last="E51413">
<title>Microarray-assisted pathway analysis identifies MT1X &amp; NFkappaB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.</title>
<authorList>
<person name="Peng B."/>
<person name="Gu Y."/>
<person name="Xiong Y."/>
<person name="Zheng G."/>
<person name="He Z."/>
</authorList>
<dbReference type="PubMed" id="23251525"/>
<dbReference type="DOI" id="10.1371/journal.pone.0051413"/>
</citation>
<scope>INTERACTION WITH FAM168A</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="60">
<citation type="journal article" date="2013" name="Oncotarget" volume="4" first="729" last="738">
<title>FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.</title>
<authorList>
<person name="Cipriano R."/>
<person name="Miskimen K.L."/>
<person name="Bryson B.L."/>
<person name="Foy C.R."/>
<person name="Bartel C.A."/>
<person name="Jackson M.W."/>
</authorList>
<dbReference type="PubMed" id="23676467"/>
</citation>
<scope>INTERACTION WITH FAM83B</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2002" name="Cell. Signal." volume="14" first="381" last="395">
<title>The protein kinase B/Akt signalling pathway in human malignancy.</title>
<authorList>
<person name="Nicholson K.M."/>
<person name="Anderson N.G."/>
</authorList>
<dbReference type="PubMed" id="11882383"/>
<dbReference type="DOI" id="10.1016/S0898-6568(01)00271-6"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2010" name="Mol. Cancer Ther." volume="9" first="2934" last="2942">
<title>A novel human dynactin-associated protein, dynAP, promotes activation of Akt, and ergosterol-related compounds induce dynAP-dependent apoptosis of human cancer cells.</title>
<authorList>
<person name="Kunoh T."/>
<person name="Noda T."/>
<person name="Koseki K."/>
<person name="Sekigawa M."/>
<person name="Takagi M."/>
<person name="Shin-ya K."/>
<person name="Goshima N."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Wada S."/>
<person name="Mukai Y."/>
<person name="Ohta S."/>
<person name="Sasaki R."/>
<person name="Mizukami T."/>
</authorList>
<dbReference type="PubMed" id="20978158"/>
<dbReference type="DOI" id="10.1158/1535-7163.MCT-10-0730"/>
</citation>
<scope>PHOSPHORYLATION AT SER-473</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2011" name="Cell. Signal." volume="23" first="1515" last="1527">
<title>Akt signalling in health and disease.</title>
<authorList>
<person name="Hers I."/>
<person name="Vincent E.E."/>
<person name="Tavare J.M."/>
</authorList>
<dbReference type="PubMed" id="21620960"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2011.05.004"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2011" name="Histol. Histopathol." volume="26" first="651" last="662">
<title>Akt1 and Akt2: differentiating the aktion.</title>
<authorList>
<person name="Heron-Milhavet L."/>
<person name="Khouya N."/>
<person name="Fernandez A."/>
<person name="Lamb N.J."/>
</authorList>
<dbReference type="PubMed" id="21432781"/>
<dbReference type="DOI" id="10.14670/HH-26.651"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="6474" last="6479">
<title>IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.</title>
<authorList>
<person name="Xie X."/>
<person name="Zhang D."/>
<person name="Zhao B."/>
<person name="Lu M.K."/>
<person name="You M."/>
<person name="Condorelli G."/>
<person name="Wang C.Y."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="21464307"/>
<dbReference type="DOI" id="10.1073/pnas.1016132108"/>
</citation>
<scope>PHOSPHORYLATION AT THR-308 AND SER-473</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RA46" last="RA46">
<title>The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.</title>
<authorList>
<person name="Sundaresan N.R."/>
<person name="Pillai V.B."/>
<person name="Wolfgeher D."/>
<person name="Samant S."/>
<person name="Vasudevan P."/>
<person name="Parekh V."/>
<person name="Raghuraman H."/>
<person name="Cunningham J.M."/>
<person name="Gupta M."/>
<person name="Gupta M.P."/>
</authorList>
<dbReference type="PubMed" id="21775285"/>
<dbReference type="DOI" id="10.1126/scisignal.2001465"/>
</citation>
<scope>INTERACTION WITH SIRT1</scope>
<scope>ACETYLATION AT LYS-14 AND LYS-20</scope>
<scope>DEACETYLATION AT LYS-14 AND LYS-20</scope>
<scope>MUTAGENESIS OF LYS-14; GLU-17 AND LYS-20</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2012" name="Cell Res." volume="22" first="873" last="885">
<title>Akt is negatively regulated by the MULAN E3 ligase.</title>
<authorList>
<person name="Bae S."/>
<person name="Kim S.Y."/>
<person name="Jung J.H."/>
<person name="Yoon Y."/>
<person name="Cha H.J."/>
<person name="Lee H."/>
<person name="Kim K."/>
<person name="Kim J."/>
<person name="An I.S."/>
<person name="Kim J."/>
<person name="Um H.D."/>
<person name="Park I.C."/>
<person name="Lee S.J."/>
<person name="Nam S.Y."/>
<person name="Jin Y.W."/>
<person name="Lee J.H."/>
<person name="An S."/>
</authorList>
<dbReference type="PubMed" id="22410793"/>
<dbReference type="DOI" id="10.1038/cr.2012.38"/>
</citation>
<scope>UBIQUITINATION AT LYS-284</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E37427" last="E37427">
<title>Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling.</title>
<authorList>
<person name="Wang S."/>
<person name="Huang X."/>
<person name="Sun D."/>
<person name="Xin X."/>
<person name="Pan Q."/>
<person name="Peng S."/>
<person name="Liang Z."/>
<person name="Luo C."/>
<person name="Yang Y."/>
<person name="Jiang H."/>
<person name="Huang M."/>
<person name="Chai W."/>
<person name="Ding J."/>
<person name="Geng M."/>
</authorList>
<dbReference type="PubMed" id="22629392"/>
<dbReference type="DOI" id="10.1371/journal.pone.0037427"/>
</citation>
<scope>GLYCOSYLATION AT SER-126; SER-129; THR-305 AND THR-312</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PDPK1</scope>
<scope>MUTAGENESIS OF THR-305 AND THR-312</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E65679" last="E65679">
<title>CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site.</title>
<authorList>
<person name="Zhuo D.X."/>
<person name="Zhang X.W."/>
<person name="Jin B."/>
<person name="Zhang Z."/>
<person name="Xie B.S."/>
<person name="Wu C.L."/>
<person name="Gong K."/>
<person name="Mao Z.B."/>
</authorList>
<dbReference type="PubMed" id="23799035"/>
<dbReference type="DOI" id="10.1371/journal.pone.0065679"/>
</citation>
<scope>PHOSPHORYLATION AT SER-473</scope>
<scope>DEPHOSPHORYLATION BY CPPED1</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="3895" last="3900">
<title>MOZ increases p53 acetylation and premature senescence through its complex formation with PML.</title>
<authorList>
<person name="Rokudai S."/>
<person name="Laptenko O."/>
<person name="Arnal S.M."/>
<person name="Taya Y."/>
<person name="Kitabayashi I."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="23431171"/>
<dbReference type="DOI" id="10.1073/pnas.1300490110"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-448 AND THR-450</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="73">
<citation type="journal article" date="2014" name="Neoplasia" volume="16" first="247" last="256">
<title>KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.</title>
<authorList>
<person name="Singel S.M."/>
<person name="Cornelius C."/>
<person name="Zaganjor E."/>
<person name="Batten K."/>
<person name="Sarode V.R."/>
<person name="Buckley D.L."/>
<person name="Peng Y."/>
<person name="John G.B."/>
<person name="Li H.C."/>
<person name="Sadeghi N."/>
<person name="Wright W.E."/>
<person name="Lum L."/>
<person name="Corson T.W."/>
<person name="Shay J.W."/>
</authorList>
<dbReference type="PubMed" id="24784001"/>
<dbReference type="DOI" id="10.1016/j.neo.2014.03.008"/>
</citation>
<scope>INTERACTION WITH KIF14</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="1256" last="1262">
<title>High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate.</title>
<authorList>
<person name="Thomas C.C."/>
<person name="Deak M."/>
<person name="Alessi D.R."/>
<person name="van Aalten D.M."/>
</authorList>
<dbReference type="PubMed" id="12176338"/>
<dbReference type="DOI" id="10.1016/S0960-9822(02)00972-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 1-123</scope>
<scope>INTERACTION WITH PTDINS(3,4,5)P3 AND PTDINS(3,4)P2</scope>
<scope>MUTAGENESIS OF LYS-14; ARG-25 AND ARG-86</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2003" name="Biochem. J." volume="375" first="531" last="538">
<title>Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change.</title>
<authorList>
<person name="Milburn C.C."/>
<person name="Deak M."/>
<person name="Kelly S.M."/>
<person name="Price N.C."/>
<person name="Alessi D.R."/>
<person name="Van Aalten D.M."/>
</authorList>
<dbReference type="PubMed" id="12964941"/>
<dbReference type="DOI" id="10.1042/BJ20031229"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (0.98 ANGSTROMS) OF 1-121</scope>
<scope>INTERACTION WITH PTDINS(1,3,4,5)P4</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2008" name="Bioorg. Med. Chem. Lett." volume="18" first="3359" last="3363">
<title>Synthesis and structure based optimization of novel Akt inhibitors.</title>
<authorList>
<person name="Lippa B."/>
<person name="Pan G."/>
<person name="Corbett M."/>
<person name="Li C."/>
<person name="Kauffman G.S."/>
<person name="Pandit J."/>
<person name="Robinson S."/>
<person name="Wei L."/>
<person name="Kozina E."/>
<person name="Marr E.S."/>
<person name="Borzillo G."/>
<person name="Knauth E."/>
<person name="Barbacci-Tobin E.G."/>
<person name="Vincent P."/>
<person name="Troutman M."/>
<person name="Baker D."/>
<person name="Rajamohan F."/>
<person name="Kakar S."/>
<person name="Clark T."/>
<person name="Morris J."/>
</authorList>
<dbReference type="PubMed" id="18456494"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2008.04.034"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 144-480</scope>
<scope>PHOSPHORYLATION AT THR-308</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="5607" last="5612">
<title>Discovery of pyrrolopyrimidine inhibitors of Akt.</title>
<authorList>
<person name="Blake J.F."/>
<person name="Kallan N.C."/>
<person name="Xiao D."/>
<person name="Xu R."/>
<person name="Bencsik J.R."/>
<person name="Skelton N.J."/>
<person name="Spencer K.L."/>
<person name="Mitchell I.S."/>
<person name="Woessner R.D."/>
<person name="Gloor S.L."/>
<person name="Risom T."/>
<person name="Gross S.D."/>
<person name="Martinson M."/>
<person name="Morales T.H."/>
<person name="Vigers G.P."/>
<person name="Brandhuber B.J."/>
</authorList>
<dbReference type="PubMed" id="20810279"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.08.053"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 144-480</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2010" name="J. Med. Chem." volume="53" first="4615" last="4622">
<title>Design of selective, ATP-competitive inhibitors of Akt.</title>
<authorList>
<person name="Freeman-Cook K.D."/>
<person name="Autry C."/>
<person name="Borzillo G."/>
<person name="Gordon D."/>
<person name="Barbacci-Tobin E."/>
<person name="Bernardo V."/>
<person name="Briere D."/>
<person name="Clark T."/>
<person name="Corbett M."/>
<person name="Jakubczak J."/>
<person name="Kakar S."/>
<person name="Knauth E."/>
<person name="Lippa B."/>
<person name="Luzzio M.J."/>
<person name="Mansour M."/>
<person name="Martinelli G."/>
<person name="Marx M."/>
<person name="Nelson K."/>
<person name="Pandit J."/>
<person name="Rajamohan F."/>
<person name="Robinson S."/>
<person name="Subramanyam C."/>
<person name="Wei L."/>
<person name="Wythes M."/>
<person name="Morris J."/>
</authorList>
<dbReference type="PubMed" id="20481595"/>
<dbReference type="DOI" id="10.1021/jm1003842"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 144-480</scope>
<scope>PHOSPHORYLATION AT THR-308</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E12913" last="E12913">
<title>Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.</title>
<authorList>
<person name="Wu W.I."/>
<person name="Voegtli W.C."/>
<person name="Sturgis H.L."/>
<person name="Dizon F.P."/>
<person name="Vigers G.P."/>
<person name="Brandhuber B.J."/>
</authorList>
<dbReference type="PubMed" id="20886116"/>
<dbReference type="DOI" id="10.1371/journal.pone.0012913"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 2-443</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2011" name="Bioorg. Med. Chem. Lett." volume="21" first="2410" last="2414">
<title>Discovery and SAR of spirochromane Akt inhibitors.</title>
<authorList>
<person name="Kallan N.C."/>
<person name="Spencer K.L."/>
<person name="Blake J.F."/>
<person name="Xu R."/>
<person name="Heizer J."/>
<person name="Bencsik J.R."/>
<person name="Mitchell I.S."/>
<person name="Gloor S.L."/>
<person name="Martinson M."/>
<person name="Risom T."/>
<person name="Gross S.D."/>
<person name="Morales T.H."/>
<person name="Wu W.I."/>
<person name="Vigers G.P."/>
<person name="Brandhuber B.J."/>
<person name="Skelton N.J."/>
</authorList>
<dbReference type="PubMed" id="21392984"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2011.02.073"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 144-480</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2007" name="Nature" volume="448" first="439" last="444">
<title>A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.</title>
<authorList>
<person name="Carpten J.D."/>
<person name="Faber A.L."/>
<person name="Horn C."/>
<person name="Donoho G.P."/>
<person name="Briggs S.L."/>
<person name="Robbins C.M."/>
<person name="Hostetter G."/>
<person name="Boguslawski S."/>
<person name="Moses T.Y."/>
<person name="Savage S."/>
<person name="Uhlik M."/>
<person name="Lin A."/>
<person name="Du J."/>
<person name="Qian Y.-W."/>
<person name="Zeckner D.J."/>
<person name="Tucker-Kellogg G."/>
<person name="Touchman J."/>
<person name="Patel K."/>
<person name="Mousses S."/>
<person name="Bittner M."/>
<person name="Schevitz R."/>
<person name="Lai M.-H.T."/>
<person name="Blanchard K.L."/>
<person name="Thomas J.E."/>
</authorList>
<dbReference type="PubMed" id="17611497"/>
<dbReference type="DOI" id="10.1038/nature05933"/>
</citation>
<scope>VARIANT BREAST CANCER LYS-17</scope>
<scope>CHARACTERIZATION OF VARIANT BREAST CANCER LYS-17</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="12260" last="12269">
<title>Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain.</title>
<authorList>
<person name="Landgraf K.E."/>
<person name="Pilling C."/>
<person name="Falke J.J."/>
</authorList>
<dbReference type="PubMed" id="18954143"/>
<dbReference type="DOI" id="10.1021/bi801683k"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT PROTEUSS LYS-17</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2011" name="N. Engl. J. Med." volume="365" first="611" last="619">
<title>A mosaic activating mutation in AKT1 associated with the Proteus syndrome.</title>
<authorList>
<person name="Lindhurst M.J."/>
<person name="Sapp J.C."/>
<person name="Teer J.K."/>
<person name="Johnston J.J."/>
<person name="Finn E.M."/>
<person name="Peters K."/>
<person name="Turner J."/>
<person name="Cannons J.L."/>
<person name="Bick D."/>
<person name="Blakemore L."/>
<person name="Blumhorst C."/>
<person name="Brockmann K."/>
<person name="Calder P."/>
<person name="Cherman N."/>
<person name="Deardorff M.A."/>
<person name="Everman D.B."/>
<person name="Golas G."/>
<person name="Greenstein R.M."/>
<person name="Kato B.M."/>
<person name="Keppler-Noreuil K.M."/>
<person name="Kuznetsov S.A."/>
<person name="Miyamoto R.T."/>
<person name="Newman K."/>
<person name="Ng D."/>
<person name="O'Brien K."/>
<person name="Rothenberg S."/>
<person name="Schwartzentruber D.J."/>
<person name="Singhal V."/>
<person name="Tirabosco R."/>
<person name="Upton J."/>
<person name="Wientroub S."/>
<person name="Zackai E.H."/>
<person name="Hoag K."/>
<person name="Whitewood-Neal T."/>
<person name="Robey P.G."/>
<person name="Schwartzberg P.L."/>
<person name="Darling T.N."/>
<person name="Tosi L.L."/>
<person name="Mullikin J.C."/>
<person name="Biesecker L.G."/>
</authorList>
<dbReference type="PubMed" id="21793738"/>
<dbReference type="DOI" id="10.1056/NEJMoa1104017"/>
</citation>
<scope>VARIANT PROTEUSS LYS-17</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="92" first="76" last="80">
<title>Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.</title>
<authorList>
<person name="Orloff M.S."/>
<person name="He X."/>
<person name="Peterson C."/>
<person name="Chen F."/>
<person name="Chen J.L."/>
<person name="Mester J.L."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="23246288"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2012.10.021"/>
</citation>
<scope>VARIANTS CWS6 CYS-25 AND PRO-435</scope>
</reference>
<comment type="function">
<text>AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro-apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53.</text>
</comment>
<comment type="function">
<text>AKT1-specific substrates have been recently identified, including palladin (PALLD), which phosphorylation modulates cytoskeletal organization and cell motility; prohibitin (PHB), playing an important role in cell metabolism and proliferation; and CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation. Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation.</text>
</comment>
<comment type="catalytic activity">
<text evidence="32 38 43">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="42 51 53 58 70 71">Three specific sites, one in the kinase domain (Thr-308) and the two other ones in the C-terminal regulatory region (Ser-473 and Tyr-474), need to be phosphorylated for its full activation. Inhibited by pyrrolopyrimidine inhibitors like aniline triazole and spiroindoline.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="35">52.8 uM for ATP (for purified and in vitro activated AKT1)</KM>
<KM evidence="35">0.5 uM for peptide substrate (for purified and in vitro activated AKT1)</KM>
<KM evidence="35">143.3 uM for ATP (for recombinant myristoylated AKT1 expressed and immunoprecipitated from Rat-1 cells)</KM>
<KM evidence="35">2.9 uM for peptide substrate (for recombinant myristoylated AKT1 expressed and immunoprecipitated from Rat-1 cells)</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="10 11 15 16 17 18 19 20 21 22 24 25 26 27 28 30 32 34 36 40 41 45 46 48 49 50 52 56 57 60 63 65 66 68">Interacts with BTBD10 (By similarity). Interacts with KCTD20 (By similarity). Interacts (via the C-terminus) with CCDC88A (via its C-terminus). Interacts with GRB10; the interaction leads to GRB10 phosphorylation thus promoting YWHAE-binding (By similarity). Interacts with AGAP2 (isoform 2/PIKE-A); the interaction occurs in the presence of guanine nucleotides. Interacts with AKTIP. Interacts (via PH domain) with MTCP1, TCL1A AND TCL1B. Interacts with CDKN1B; the interaction phosphorylates CDKN1B promoting 14-3-3 binding and cell-cycle progression. Interacts with MAP3K5 and TRAF6. Interacts with BAD, PPP2R5B, STK3 and STK4. Interacts (via PH domain) with SIRT1. Interacts with SRPK2 in a phosphorylation-dependent manner. Interacts with RAF1. Interacts with TRIM13; the interaction ubiquitinates AKT1 leading to its proteasomal degradation. Interacts with TNK2 and CLK2. Interacts (via the C-terminus) with THEM4 (via its C-terminus). Interacts with and phosphorylated by PDPK1. Interacts with PA2G4 (By similarity). Interacts with KIF14; the interaction is detected in the plasma membrane upon INS stimulation and promotes AKT1 phosphorylation (PubMed:24784001). Interacts with FAM83B; activates the PI3K/AKT signaling cascade (PubMed:23676467). Interacts with WDFY2 (via WD repeats 1-3) (PubMed:16792529). Forms a complex with WDFY2 and FOXO1 (By similarity). Interacts with FAM168A (PubMed:23251525).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-296087"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-347640">
<id>Q86V81</id>
<label>ALYREF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-741243">
<id>Q9UKG1</id>
<label>APPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1636616">
<id>P29067</id>
<label>Arrb2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1646500">
<id>Q8IXJ9</id>
<label>ASXL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-958922">
<id>O95999</id>
<label>BCL10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-457097">
<id>P20248</id>
<label>CCNA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-719459">
<id>P26358</id>
<label>DNMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-3942563">
<id>Q1W6H9</id>
<label>FAM110C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-6916466">
<id>Q9BZQ8</id>
<label>FAM129A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1108782">
<id>Q12778</id>
<label>FOXO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1644164">
<id>O43524</id>
<label>FOXO3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-354921">
<id>P11021</id>
<label>HSPA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-465548">
<id>Q14643</id>
<label>ITPR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-5323863">
<id>Q5S007</id>
<label>LRRK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-6859930">
<id>Q83730</id>
<label>m005R</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-476263">
<id>Q99683</id>
<label>MAP3K5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-73946">
<id>Q16539</id>
<label>MAPK14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-366182">
<id>P10636</id>
<label>MAPT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-359260">
<id>P42345</id>
<label>MTOR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1391623">
<id>P29474</id>
<label>NOS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-493507">
<id>P04150</id>
<label>NR3C1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12562306"/>
<interactant intactId="EBI-12562315">
<id>Q15118-1</id>
<label>PDK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-717097">
<id>O15530</id>
<label>PDPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-8563667">
<id>Q96S96</id>
<label>PEBP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-368321">
<id>O60437</id>
<label>PPL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-357253">
<id>P62136</id>
<label>PPP1CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-712311">
<id>P67775</id>
<label>PPP2CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-302388">
<id>P30153</id>
<label>PPP2R1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-295351">
<id>Q05513</id>
<label>PRKCZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1775921">
<id>P23443</id>
<label>RPS6KB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-79691">
<id>Q15047</id>
<label>SETDB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-347263">
<id>Q13485</id>
<label>SMAD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-367376">
<id>Q13043</id>
<label>STK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-15687717">
<id>Q9UNE7-1</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-749995">
<id>P56279</id>
<label>TCL1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-750109">
<id>Q9NYB0</id>
<label>TERF2IP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-7684443">
<id>Q5T1C6</id>
<label>THEM4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-308302">
<id>Q92547</id>
<label>TOPBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-353844">
<id>P08670</id>
<label>VIM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>29</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296087"/>
<interactant intactId="EBI-7683985">
<id>P03165</id>
<label>X</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<text evidence="36">Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and Ser-473 leading to its activation and the activated form translocates to the nucleus. Colocalizes with WDFY2 in intracellular vesicles (PubMed:16792529).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P31749-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P31749-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056180"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="38 41 50">Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages.</text>
</comment>
<comment type="domain">
<text>Binding of the PH domain to phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) following phosphatidylinositol 3-kinase alpha (PIK3CA) activity results in its targeting to the plasma membrane. The PH domain mediates interaction with TNK2 and Tyr-176 is also essential for this interaction.</text>
</comment>
<comment type="domain">
<text>The AGC-kinase C-terminal mediates interaction with THEM4.</text>
</comment>
<comment type="PTM">
<text evidence="28 29 31 33 37 42 50 51 55 59 67 69 70 71">O-GlcNAcylation at Thr-305 and Thr-312 inhibits activating phosphorylation at Thr-308 via disrupting the interaction between AKT1 and PDPK1. O-GlcNAcylation at Ser-473 also probably interferes with phosphorylation at this site.</text>
</comment>
<comment type="PTM">
<text evidence="23 28 29 31 33 37 42 50 51 55 59 67 69 70 71">Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308 and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1. Phosphorylated at Thr-308 and Ser-473 by IKBKE and TBK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells. Ser-473 phosphorylation is enhanced by signaling through activated FLT3. Dephosphorylated at Thr-308 and Ser-473 by PP2A phosphatase. The phosphorylated form of PPP2R5B is required for bridging AKT1 with PP2A phosphatase. Ser-473 is dephosphorylated by CPPED1, leading to termination of signaling.</text>
</comment>
<comment type="PTM">
<text evidence="9 46 47 57 62">Ubiquitinated via 'Lys-48'-linked polyubiquitination by ZNRF1, leading to its degradation by the proteasome (By similarity). Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. Also ubiquitinated by TRIM13 leading to its proteasomal degradation. Phosphorylated, undergoes 'Lys-48'-linked polyubiquitination preferentially at Lys-284 catalyzed by MUL1, leading to its proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="60">Acetylated on Lys-14 and Lys-20 by the histone acetyltransferases EP300 and KAT2B. Acetylation results in reduced phosphorylation and inhibition of activity. Deacetylated at Lys-14 and Lys-20 by SIRT1. SIRT1-mediated deacetylation relieves the inhibition.</text>
</comment>
<comment type="disease" evidence="39">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01359">
<name>Colorectal cancer</name>
<acronym>CRC</acronym>
<description>A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.</description>
<dbReference type="MIM" id="114500"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<text>Genetic variations in AKT1 may play a role in susceptibility to ovarian cancer.</text>
</comment>
<comment type="disease" evidence="44 61">
<disease id="DI-03216">
<name>Proteus syndrome</name>
<acronym>PROTEUSS</acronym>
<description>A highly variable, severe disorder of asymmetric and disproportionate overgrowth of body parts, connective tissue nevi, epidermal nevi, dysregulated adipose tissue, and vascular malformations. Many features of Proteus syndrome overlap with other overgrowth syndromes.</description>
<dbReference type="MIM" id="176920"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="64">
<disease id="DI-03697">
<name>Cowden syndrome 6</name>
<acronym>CWS6</acronym>
<description>A form of Cowden syndrome, a hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid.</description>
<dbReference type="MIM" id="615109"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="73">Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.</text>
</comment>
<comment type="caution">
<text evidence="73">In light of strong homologies in the primary amino acid sequence, the 3 AKT kinases were long surmised to play redundant and overlapping roles. More recent studies has brought into question the redundancy within AKT kinase isoforms and instead pointed to isoform specific functions in different cellular events and diseases. AKT1 is more specifically involved in cellular survival pathways, by inhibiting apoptotic processes; whereas AKT2 is more specific for the insulin receptor signaling pathway. Moreover, while AKT1 and AKT2 are often implicated in many aspects of cellular transformation, the 2 isoforms act in a complementary opposing manner. The role of AKT3 is less clear, though it appears to be predominantly expressed in brain.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/AKT1ID355ch14q32.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="M63167">
<property type="protein sequence ID" value="AAA36539.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283830">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283819">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283820">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283821">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283822">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283823">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283824">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283825">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283826">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283827">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283828">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283829">
<property type="protein sequence ID" value="AAL55732.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK299310">
<property type="protein sequence ID" value="BAH12997.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314256">
<property type="protein sequence ID" value="BAG36922.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451242">
<property type="protein sequence ID" value="BAG70056.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451367">
<property type="protein sequence ID" value="BAG70181.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL583722">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590327">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000479">
<property type="protein sequence ID" value="AAH00479.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC084538">
<property type="protein sequence ID" value="AAH84538.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X61037">
<property type="protein sequence ID" value="CAA43372.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9994.1">
<molecule id="P31749-1"/>
</dbReference>
<dbReference type="PIR" id="A39360">
<property type="entry name" value="A39360"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001014431.1">
<molecule id="P31749-1"/>
<property type="nucleotide sequence ID" value="NM_001014431.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001014432.1">
<molecule id="P31749-1"/>
<property type="nucleotide sequence ID" value="NM_001014432.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005154.2">
<molecule id="P31749-1"/>
<property type="nucleotide sequence ID" value="NM_005163.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005267458.1">
<molecule id="P31749-1"/>
<property type="nucleotide sequence ID" value="XM_005267401.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.525622"/>
<dbReference type="PDB" id="1H10">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="1UNP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=1-121"/>
</dbReference>
<dbReference type="PDB" id="1UNQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="0.98"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="1UNR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="2UVM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="2UZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="2UZS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.46"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="3CQU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="3CQW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="3MV5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="3MVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="3O96">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=2-443"/>
</dbReference>
<dbReference type="PDB" id="3OCB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=144-480"/>
</dbReference>
<dbReference type="PDB" id="3OW4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=144-480"/>
</dbReference>
<dbReference type="PDB" id="3QKK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="3QKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="3QKM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="4EJN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A=2-446"/>
</dbReference>
<dbReference type="PDB" id="4EKK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=144-480"/>
</dbReference>
<dbReference type="PDB" id="4EKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="4GV1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.49"/>
<property type="chains" value="A=144-480"/>
</dbReference>
<dbReference type="PDB" id="5KCV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=2-446"/>
</dbReference>
<dbReference type="PDBsum" id="1H10"/>
<dbReference type="PDBsum" id="1UNP"/>
<dbReference type="PDBsum" id="1UNQ"/>
<dbReference type="PDBsum" id="1UNR"/>
<dbReference type="PDBsum" id="2UVM"/>
<dbReference type="PDBsum" id="2UZR"/>
<dbReference type="PDBsum" id="2UZS"/>
<dbReference type="PDBsum" id="3CQU"/>
<dbReference type="PDBsum" id="3CQW"/>
<dbReference type="PDBsum" id="3MV5"/>
<dbReference type="PDBsum" id="3MVH"/>
<dbReference type="PDBsum" id="3O96"/>
<dbReference type="PDBsum" id="3OCB"/>
<dbReference type="PDBsum" id="3OW4"/>
<dbReference type="PDBsum" id="3QKK"/>
<dbReference type="PDBsum" id="3QKL"/>
<dbReference type="PDBsum" id="3QKM"/>
<dbReference type="PDBsum" id="4EJN"/>
<dbReference type="PDBsum" id="4EKK"/>
<dbReference type="PDBsum" id="4EKL"/>
<dbReference type="PDBsum" id="4GV1"/>
<dbReference type="PDBsum" id="5KCV"/>
<dbReference type="ProteinModelPortal" id="P31749"/>
<dbReference type="SMR" id="P31749"/>
<dbReference type="BioGrid" id="106710">
<property type="interactions" value="302"/>
</dbReference>
<dbReference type="CORUM" id="P31749"/>
<dbReference type="DIP" id="DIP-24269N"/>
<dbReference type="ELM" id="P31749"/>
<dbReference type="IntAct" id="P31749">
<property type="interactions" value="163"/>
</dbReference>
<dbReference type="MINT" id="MINT-203775"/>
<dbReference type="STRING" id="9606.ENSP00000270202"/>
<dbReference type="BindingDB" id="P31749"/>
<dbReference type="ChEMBL" id="CHEMBL4282"/>
<dbReference type="DrugBank" id="DB00171">
<property type="generic name" value="Adenosine triphosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01169">
<property type="generic name" value="Arsenic trioxide"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1479"/>
<dbReference type="iPTMnet" id="P31749"/>
<dbReference type="PhosphoSitePlus" id="P31749"/>
<dbReference type="BioMuta" id="AKT1"/>
<dbReference type="DMDM" id="60391226"/>
<dbReference type="EPD" id="P31749"/>
<dbReference type="MaxQB" id="P31749"/>
<dbReference type="PaxDb" id="P31749"/>
<dbReference type="PeptideAtlas" id="P31749"/>
<dbReference type="PRIDE" id="P31749"/>
<dbReference type="DNASU" id="207"/>
<dbReference type="Ensembl" id="ENST00000349310">
<molecule id="P31749-1"/>
<property type="protein sequence ID" value="ENSP00000270202"/>
<property type="gene ID" value="ENSG00000142208"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402615">
<molecule id="P31749-1"/>
<property type="protein sequence ID" value="ENSP00000385326"/>
<property type="gene ID" value="ENSG00000142208"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000407796">
<molecule id="P31749-1"/>
<property type="protein sequence ID" value="ENSP00000384293"/>
<property type="gene ID" value="ENSG00000142208"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000554581">
<molecule id="P31749-1"/>
<property type="protein sequence ID" value="ENSP00000451828"/>
<property type="gene ID" value="ENSG00000142208"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000554848">
<molecule id="P31749-1"/>
<property type="protein sequence ID" value="ENSP00000451166"/>
<property type="gene ID" value="ENSG00000142208"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000555528">
<molecule id="P31749-1"/>
<property type="protein sequence ID" value="ENSP00000450688"/>
<property type="gene ID" value="ENSG00000142208"/>
</dbReference>
<dbReference type="GeneID" id="207"/>
<dbReference type="KEGG" id="hsa:207"/>
<dbReference type="UCSC" id="uc001ypk.4">
<molecule id="P31749-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="207"/>
<dbReference type="DisGeNET" id="207"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000142208.15"/>
<dbReference type="GeneCards" id="AKT1"/>
<dbReference type="GeneReviews" id="AKT1"/>
<dbReference type="HGNC" id="HGNC:391">
<property type="gene designation" value="AKT1"/>
</dbReference>
<dbReference type="HPA" id="CAB003765"/>
<dbReference type="HPA" id="HPA002891"/>
<dbReference type="MalaCards" id="AKT1"/>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="114500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164730">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="176920">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615109">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P31749"/>
<dbReference type="OpenTargets" id="ENSG00000142208"/>
<dbReference type="Orphanet" id="201">
<property type="disease" value="Cowden syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="744">
<property type="disease" value="Proteus syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24684"/>
<dbReference type="eggNOG" id="KOG0598">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNPH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00890000139324"/>
<dbReference type="HOGENOM" id="HOG000233033"/>
<dbReference type="HOVERGEN" id="HBG108317"/>
<dbReference type="InParanoid" id="P31749"/>
<dbReference type="KO" id="K04456"/>
<dbReference type="OMA" id="QHRFFAS"/>
<dbReference type="OrthoDB" id="EOG091G06FF"/>
<dbReference type="PhylomeDB" id="P31749"/>
<dbReference type="TreeFam" id="TF102004"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111447">
<property type="pathway name" value="Activation of BAD and translocation to mitochondria"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1358803">
<property type="pathway name" value="Downregulation of ERBB2:ERBB3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1445148">
<property type="pathway name" value="Translocation of GLUT4 to the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1474151">
<property type="pathway name" value="Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-165159">
<property type="pathway name" value="mTOR signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198323">
<property type="pathway name" value="AKT phosphorylates targets in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198693">
<property type="pathway name" value="AKT phosphorylates targets in the nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-199418">
<property type="pathway name" value="Negative regulation of the PI3K/AKT network"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-203615">
<property type="pathway name" value="eNOS activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211163">
<property type="pathway name" value="AKT-mediated inactivation of FOXO1A"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-354192">
<property type="pathway name" value="Integrin alphaIIb beta3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3769402">
<property type="pathway name" value="Deactivation of the beta-catenin transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389357">
<property type="pathway name" value="CD28 dependent PI3K/Akt signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389513">
<property type="pathway name" value="CTLA4 inhibitory signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-392451">
<property type="pathway name" value="G beta:gamma signalling through PI3Kgamma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450385">
<property type="pathway name" value="Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450604">
<property type="pathway name" value="KSRP (KHSRP) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218920">
<property type="pathway name" value="VEGFR2 mediated vascular permeability"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5628897">
<property type="pathway name" value="TP53 Regulates Metabolic Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674400">
<property type="pathway name" value="Constitutive Signaling by AKT1 E17K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and 13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804758">
<property type="pathway name" value="Regulation of TP53 Activity through Acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804759">
<property type="pathway name" value="Regulation of TP53 Activity through Association with Co-factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69202">
<property type="pathway name" value="Cyclin E associated events during G1/S transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849469">
<property type="pathway name" value="PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8876198">
<property type="pathway name" value="RAB GEFs exchange GTP for GDP on RABs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941332">
<property type="pathway name" value="RUNX2 regulates genes involved in cell migration"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8948751">
<property type="pathway name" value="Regulation of PTEN stability and activity"/>
</dbReference>
<dbReference type="SABIO-RK" id="P31749"/>
<dbReference type="SignaLink" id="P31749"/>
<dbReference type="SIGNOR" id="P31749"/>
<dbReference type="ChiTaRS" id="AKT1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P31749"/>
<dbReference type="GeneWiki" id="AKT1"/>
<dbReference type="GenomeRNAi" id="207"/>
<dbReference type="PMAP-CutDB" id="P31749"/>
<dbReference type="PRO" id="PR:P31749"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000142208"/>
<dbReference type="CleanEx" id="HS_AKT1"/>
<dbReference type="ExpressionAtlas" id="P31749">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P31749">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036064">
<property type="term" value="C:ciliary basal body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015630">
<property type="term" value="C:microtubule cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098794">
<property type="term" value="C:postsynapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071889">
<property type="term" value="F:14-3-3 protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032794">
<property type="term" value="F:GTPase activating protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030235">
<property type="term" value="F:nitric-oxide synthase regulator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005547">
<property type="term" value="F:phosphatidylinositol-3,4,5-trisphosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043325">
<property type="term" value="F:phosphatidylinositol-3,4-bisphosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051721">
<property type="term" value="F:protein phosphatase 2A binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032148">
<property type="term" value="P:activation of protein kinase B activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006924">
<property type="term" value="P:activation-induced cell death of T cells"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043276">
<property type="term" value="P:anoikis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008637">
<property type="term" value="P:apoptotic mitochondrial changes"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030030">
<property type="term" value="P:cell projection organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006464">
<property type="term" value="P:cellular protein modification process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071276">
<property type="term" value="P:cellular response to cadmium ion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097011">
<property type="term" value="P:cellular response to granulocyte macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990090">
<property type="term" value="P:cellular response to nerve growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071380">
<property type="term" value="P:cellular response to prostaglandin E stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035924">
<property type="term" value="P:cellular response to vascular endothelial growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099565">
<property type="term" value="P:chemical synaptic transmission, postsynaptic"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031018">
<property type="term" value="P:endocrine pancreas development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072655">
<property type="term" value="P:establishment of protein localization to mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097194">
<property type="term" value="P:execution phase of apoptosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G-protein coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007281">
<property type="term" value="P:germ cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006006">
<property type="term" value="P:glucose metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0015758">
<property type="term" value="P:glucose transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005978">
<property type="term" value="P:glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060709">
<property type="term" value="P:glycogen cell differentiation involved in embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030212">
<property type="term" value="P:hyaluronan metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048009">
<property type="term" value="P:insulin-like growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035655">
<property type="term" value="P:interleukin-18-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0060716">
<property type="term" value="P:labyrinthine layer blood vessel development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072656">
<property type="term" value="P:maintenance of protein location in mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060644">
<property type="term" value="P:mammary gland epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001893">
<property type="term" value="P:maternal placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010507">
<property type="term" value="P:negative regulation of autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045792">
<property type="term" value="P:negative regulation of cell size"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010951">
<property type="term" value="P:negative regulation of endopeptidase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001240">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031999">
<property type="term" value="P:negative regulation of fatty acid beta-oxidation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046329">
<property type="term" value="P:negative regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016242">
<property type="term" value="P:negative regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902176">
<property type="term" value="P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010748">
<property type="term" value="P:negative regulation of plasma membrane long-chain fatty acid transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006469">
<property type="term" value="P:negative regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0100002">
<property type="term" value="P:negative regulation of protein kinase activity by protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051898">
<property type="term" value="P:negative regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045861">
<property type="term" value="P:negative regulation of proteolysis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090201">
<property type="term" value="P:negative regulation of release of cytochrome c from mitochondria"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038061">
<property type="term" value="P:NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006809">
<property type="term" value="P:nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032287">
<property type="term" value="P:peripheral nervous system myelin maintenance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043536">
<property type="term" value="P:positive regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="DFLAT"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032270">
<property type="term" value="P:positive regulation of cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031659">
<property type="term" value="P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032079">
<property type="term" value="P:positive regulation of endodeoxyribonuclease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001938">
<property type="term" value="P:positive regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045742">
<property type="term" value="P:positive regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045600">
<property type="term" value="P:positive regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010763">
<property type="term" value="P:positive regulation of fibroblast migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046326">
<property type="term" value="P:positive regulation of glucose import"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010907">
<property type="term" value="P:positive regulation of glucose metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045725">
<property type="term" value="P:positive regulation of glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903721">
<property type="term" value="P:positive regulation of I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046889">
<property type="term" value="P:positive regulation of lipid biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010918">
<property type="term" value="P:positive regulation of mitochondrial membrane potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051000">
<property type="term" value="P:positive regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046622">
<property type="term" value="P:positive regulation of organ growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900182">
<property type="term" value="P:positive regulation of protein localization to nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010765">
<property type="term" value="P:positive regulation of sodium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030163">
<property type="term" value="P:protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000060">
<property type="term" value="P:protein import into nucleus, translocation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901976">
<property type="term" value="P:regulation of cell cycle checkpoint"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030334">
<property type="term" value="P:regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005979">
<property type="term" value="P:regulation of glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031641">
<property type="term" value="P:regulation of myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010975">
<property type="term" value="P:regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050999">
<property type="term" value="P:regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006417">
<property type="term" value="P:regulation of translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0034405">
<property type="term" value="P:response to fluid shear stress"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032094">
<property type="term" value="P:response to food"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060416">
<property type="term" value="P:response to growth hormone"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0009408">
<property type="term" value="P:response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1990418">
<property type="term" value="P:response to insulin-like growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070141">
<property type="term" value="P:response to UV-A"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021510">
<property type="term" value="P:spinal cord development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051146">
<property type="term" value="P:striated muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031929">
<property type="term" value="P:TOR signaling"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006412">
<property type="term" value="P:translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd05594">
<property type="entry name" value="STKc_PKB_alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000961">
<property type="entry name" value="AGC-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR034676">
<property type="entry name" value="Akt1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR017892">
<property type="entry name" value="Pkinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00169">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00433">
<property type="entry name" value="Pkinase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00133">
<property type="entry name" value="S_TK_X"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50729">
<property type="entry name" value="SSF50729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51285">
<property type="entry name" value="AGC_KINASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0119">Carbohydrate metabolism</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0313">Glucose metabolism</keyword>
<keyword id="KW-0320">Glycogen biosynthesis</keyword>
<keyword id="KW-0321">Glycogen metabolism</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0762">Sugar transport</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="RAC-alpha serine/threonine-protein kinase" id="PRO_0000085605">
<location>
<begin position="1"/>
<end position="480"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="12">
<location>
<begin position="5"/>
<end position="108"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="13">
<location>
<begin position="150"/>
<end position="408"/>
</location>
</feature>
<feature type="domain" description="AGC-kinase C-terminal">
<location>
<begin position="409"/>
<end position="480"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="13">
<location>
<begin position="156"/>
<end position="164"/>
</location>
</feature>
<feature type="region of interest" description="Inositol-(1,3,4,5)-tetrakisphosphate binding">
<location>
<begin position="14"/>
<end position="19"/>
</location>
</feature>
<feature type="region of interest" description="Inositol-(1,3,4,5)-tetrakisphosphate binding">
<location>
<begin position="23"/>
<end position="25"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitor binding">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="13 14">
<location>
<position position="274"/>
</location>
</feature>
<feature type="binding site" description="Inositol-(1,3,4,5)-tetrakisphosphate">
<location>
<position position="53"/>
</location>
</feature>
<feature type="binding site" description="Inositol-(1,3,4,5)-tetrakisphosphate">
<location>
<position position="86"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via amide nitrogen">
<location>
<position position="161"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="13">
<location>
<position position="179"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor; via amide nitrogen">
<location>
<position position="230"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor">
<location>
<position position="234"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor">
<location>
<position position="292"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="60">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="60">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="124"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="6">
<location>
<position position="126"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="5 6 7">
<location>
<position position="129"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by TNK2" evidence="50">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by IKKE, PDPK1 and TBK1" evidence="31 42 50 51 59 69 70">
<location>
<position position="308"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="448"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="450"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKE, MTOR and TBK1; alternate" evidence="28 29 31 33 37 50 55 59 67 69 71">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="23">
<location>
<position position="474"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" evidence="63">
<location>
<position position="126"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" evidence="63">
<location>
<position position="129"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) threonine" evidence="63">
<location>
<position position="305"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) threonine" evidence="63">
<location>
<position position="312"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" evidence="9">
<location>
<position position="473"/>
</location>
</feature>
<feature type="disulfide bond" evidence="54">
<location>
<begin position="60"/>
<end position="77"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="296"/>
<end position="310"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="62">
<location>
<position position="284"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056180" evidence="72">
<location>
<begin position="1"/>
<end position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In PROTEUSS and breast cancer; also detected in colorectal and ovarian cancer; somatic mutation; results in increased phosphorylation at T-308 and higher basal ubiquitination; the mutant protein is more efficiently recruited to the plasma membrane; alters phosphatidylinositiol phosphates lipid specificity of the AKT1 PH domain; dbSNP:rs121434592." id="VAR_055422" evidence="39 44 46 61">
<original>E</original>
<variation>K</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS6; dbSNP:rs397514644." id="VAR_069791" evidence="64">
<original>R</original>
<variation>C</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11555433." id="VAR_051617">
<original>V</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In CWS6; dbSNP:rs397514645." id="VAR_069792" evidence="64">
<original>T</original>
<variation>P</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation as well as IGF1-induced membrane recruitment. Decrease in ubiquitination and phosphorylation at T-308 as well as impaired association with the membrane; when associated with K-17." evidence="46">
<original>K</original>
<variation>R</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2." evidence="24 46 60">
<original>K</original>
<variation>A</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantial reduction of phosphorylation at T-308 and S-473, loss of AKT activation, and loss of binding to PIP3 as well as IGF1-induced membrane recruitment." evidence="24 46 60">
<original>K</original>
<variation>Q</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment." evidence="24 46 60">
<original>K</original>
<variation>R</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on membrane localization. Loss of membrane localization; when associated with Q-20." evidence="60">
<original>E</original>
<variation>K</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantial reduction of phosphorylation at T-308 and S-473, reduced AKT activation, and reduced binding to PIP3 as well as IGF1-induced membrane recruitment. Loss of membrane localization; when associated with K-17." evidence="60">
<original>K</original>
<variation>Q</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight increase of phosphorylation at T-308 and S-473." evidence="60">
<original>K</original>
<variation>R</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2." evidence="24">
<original>R</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2." evidence="24">
<original>R</original>
<variation>A</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant loss of interaction with TNK2. Loss of membrane localization. Significant reduction in phosphorylation on Ser-473." evidence="50">
<original>Y</original>
<variation>F</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-312." evidence="63">
<original>T</original>
<variation>A</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation at Thr-308." evidence="63">
<original>T</original>
<variation>Y</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="5-fold activation and 18-fold activation; when associated with D-473." evidence="25 69">
<original>T</original>
<variation>D</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-305." evidence="63">
<original>T</original>
<variation>A</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation at Thr-308." evidence="63">
<original>T</original>
<variation>Y</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="7-fold activation and 25-fold activation; when associated with D-308." evidence="25 69">
<original>S</original>
<variation>D</variation>
<location>
<position position="473"/>
</location>
</feature>
<feature type="mutagenesis site" description="55% inhibition of activation." evidence="23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>GR</original>
<variation>A</variation>
<location>
<begin position="173"/>
<end position="174"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>L</original>
<variation>Q</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>A</original>
<variation>R</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>S</original>
<variation>A</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>A</original>
<variation>T</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>A</original>
<variation>P</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA43372." ref="7" evidence="73">
<original>G</original>
<variation>A</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36539, 2; AAL55732, 3; BAG36922 and 4; BAG70056/BAG70181." ref="1 2 3 4" evidence="73">
<original>G</original>
<variation>S</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2"/>
<end position="4"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="6"/>
<end position="15"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="17"/>
<end position="19"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="22"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="33"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="45"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="52"/>
<end position="56"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="93"/>
<end position="115"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="147"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="150"/>
<end position="158"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="160"/>
<end position="169"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="170"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="175"/>
<end position="182"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="183"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="192"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="213"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="220"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="235"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="247"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="309"/>
<end position="311"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="318"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="330"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="354"/>
<end position="363"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="374"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="388"/>
<end position="390"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="399"/>
<end position="403"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="406"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="413"/>
<end position="417"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="430"/>
<end position="433"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="440"/>
<end position="443"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="464"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="473"/>
<end position="475"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1UNQ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MVH"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EJN"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GV1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P31750"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P47196"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10576742"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10716693"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10926925"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10983986"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11154276"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11598301"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11839817"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12042314"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12149249"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12176338"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12244301"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12964941"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14749367"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14761976"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15047712"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15118108"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15718470"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16139227"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16266983"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16417524"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16540465"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16792529"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17013611"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1718748"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17611497"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17726016"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17932490"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18456494"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1851997"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18954143"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19592491"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19713527"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20059950"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20086174"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20231902"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20333297"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20481595"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20682768"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20810279"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20886116"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20978158"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21329884"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21333377"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21392984"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21464307"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21775285"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21793738"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22410793"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22629392"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23246288"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23251525"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23676467"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23799035"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24784001"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8978681"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9512493"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9736715"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000305"/>
<sequence length="480" mass="55686" checksum="6EAFF4F8AD436714" modified="2005-02-01" version="2">
MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQC
QLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDF
RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI
LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS
RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI
KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL
ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK
LSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>